This framework describes the building blocks being laid down by the European Centre for Disease Prevention and Control (ECDC) to support and empower European Union (EU)/European Economic Area (EEA) countries and the European Commission in achieving microbial safety for substances of human origin (SoHO).
On 5 and 6 September, ECDC hosted the first joint SoHO-Net Tissues and Cells (TC) and Medically Assisted Reproduction (MAR) group meeting in Stockholm, Sweden.
This document provides an update on the safety of substances of human origin (SoHO) in relation to COVID-19. It reassesses the risk and proposes revised mitigation measures for preventing transmission through SoHO.
Repository of resources produced by national public health institutes, national ministries of health, or recognised and respected learned societies or academies.
This first update of the original guide was prompted by the evolution of the Zika virus epidemic, a new classification system for countries/areas, and recent scientific developments.
This document includes key elements to be considered in the risk-based decision-making process of mitigating the threats to the safety of substances of human origin posed by Zika virus.
In order to assist Member States with the implementation of the new requirements, the EU Commission asked ECDC to construct a map indicating HTLV-1 high-prevalence areas in the world.